Estimating meat withdrawal times in pigs exposed to melamine contaminated feed using a physiologically based pharmacokinetic model

Regulatory Toxicology and Pharmacology

Volumn 51, Issue 3, 2008, Pages 324-331

  Buur, Jennifer L ^a   Baynes, Ronald E ^a   Riviere, Jim E ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Feed contaminants; Meat withdrawal time; Melamine; PBPK; Porcine; Rat

Indexed keywords

MELAMINE;

ANIMAL EXPERIMENT; ANIMAL FOOD; ARTICLE; CARCASS; CONTROLLED STUDY; DOSE RESPONSE; FOOD CONTAMINATION; KIDNEY; LIVER; MALE; MATHEMATICAL MODEL; MEAT; NONHUMAN; PLASMA; PREDICTION; PRIORITY JOURNAL; RAT; SWINE; TISSUE DISTRIBUTION; TOXICOKINETICS;

ANIMAL FEED; ANIMALS; DRUG ADMINISTRATION SCHEDULE; DRUG RESIDUES; FOOD CONTAMINATION; MALE; MEAT PRODUCTS; MODELS, BIOLOGICAL; RATS; RATS, INBRED F344; REPRODUCIBILITY OF RESULTS; RESINS, SYNTHETIC; SWINE; TIME FACTORS; TRIAZINES;

RATTUS; SUIDAE; SUS;

EID: 47749138132     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2008.05.003     Document Type: Article

References (31)

1. Baynes R.E., Smith G., Mason S.E., Barrett E., Barlow B.M., and Riviere J.E. Pharmacokinetics of melamine in pigs following intravenous administration. Food Chem. Toxicol. 46 (2008) 1196-1200
2. Burns K. Events leading to the major recall of pet foods. J. Am. Vet. Med. Assoc. 230 (2007) 1601-1604
3. Burns K. Recall shines spotlight on pet foods. J. Am. Vet. Med. Assoc. 230 (2007) 1285-1286
4. Buur J., Baynes R., Smith G., and Riviere J. Use of probabilistic modeling within a physiologically based pharmacokinetic model to predict sulfamethazine residue withdrawal times in edible tissues in swine. Antimicrob. Agents Chemother. 50 (2006) 2344-2351
5. Buur J.L., Baynes R.E., Craigmill A.L., and Riviere J.E. Development of a physiologic-based pharmacokinetic model for estimating sulfamethazine concentrations in swine and application to prediction of violative residues in edible tissues. Am. J. Vet. Res. 66 (2005) 1686-1693
6. Cakir B., Kasimay O., Devseren E., and Yegen B.C. Leptin inhibits gastric emptying in rats: role of CCK receptors and vagal afferent fibers. Physiol. Res. 56 (2007) 315-322
7. Clewell H.J., Gentry P.R., Covington T.R., Sarangapani R., and Teeguarden J.G. Evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry. Toxicol. Sci. 79 (2004) 381-393
8. Craigmill A.L. A physiologically based pharmacokinetic model for oxytetracycline residues in sheep. J. Vet. Pharmacol. Ther. 26 (2003) 55-63
9. Gentry P.R., Covington T.R., Clewell III H.J., and Anderson M.E. Application of a physiologically based pharmacokinetic model for reference dose and reference concentration estimation for acetone. J. Toxicol. Environ. Health A 66 (2003) 2209-2225
10. Grass G.M., and Sinko P.J. Physiologically-based pharmacokinetic simulation modelling. Adv. Drug Deliv. Rev. 54 (2002) 433-451
11. Guerin S., Ramonet Y., LeCloarec J., Meunier-Salaun M.C., Bourguet P., and Malbert C.H. Changes in intragastric meal distribution are better predictors of gastric emptying rate in conscious pigs than are meal viscosity or dietary fibre concentration. Br. J. Nutr. 85 (2001) 343-350
12. Kawai R., Lemaire M., Steimer J.L., Bruelisauer A., Niederberger W., and Rowland M. Physiologically based pharmacokinetic study on a cyclosporin derivative, SDZ IMM 125. J. Pharmacokinet. Biopharm. 22 (1994) 327-365
13. Kirman C.R., Sweeney L.M., Meek M.E., and Gargas M.L. Assessing the dose-dependency of allometric scaling performance using physiologically based pharmacokinetic modeling. Regul. Toxicol. Pharmacol. 38 (2003) 345-367
14. Lundeen G., Manohar M., and Parks C. Systemic distribution of blood flow in swine while awake and during 1.0 and 1.5 MAC isoflurane anesthesia with or without 50% nitrous oxide. Anesth. Analg. 62 (1983) 499-512
15. Mast R.W., Jeffcoat A.R., Sadler B.M., Kraska R.C., and Friedman M.A. Metabolism, disposition and excretion of [14C] melamine in male Fischer 344 rats. Food Chem. Toxicol. 21 (1983) 807-810
16. Ogasawara H., Imaida K., Ishiwata H., Toyoda K., Kawanishi T., Uneyama C., Hayashi S., Takahashi M., and Hayashi Y. Urinary bladder carcinogenesis induced by melamine in F344 male rats: correlation between carcinogenicity and urolith formation. Carcinogenesis 16 (1995) 2773-2777
17. Pond W.G. Biology of the Domestic Pig (2001), Cornell University Press, Ithaca, NY
18. Puschner B., Poppenga R.H., Lowenstine L.J., Filigenzi M.S., and Pesavento P.A. Assessment of melamine and cyanuric acid toxicity in cats. J. Vet. Diagn. Invest. 19 (2007) 616-624
19. Reitz R.H., Mendrala A.L., Park C.N., Andersen M.E., and Guengerich F.P. Incorporation of in vitro enzyme data into the physiologically-based pharmacokinetic (PB-PK) model for methylene chloride: implications for risk assessment. Toxicol. Lett. 43 (1988) 97-116
20. Riviere J.E. Comparative Pharmacokinetics: Principles Techniques and Applications (1999), Blackwell Publishing, Inc., Ames, Iowa
21. Schoeffner D.J., Warren D.A., Muralidara S., Bruckner J.V., and Simmons J.E. Organ weights and fat volume in rats as a function of strain and age. J. Toxicol. Environ. Health A 56 (1999) 449-462
22. Shelby M.D., Erexson G.L., Hook G.J., and Tice R.R. Evaluation of a three-exposure mouse bone marrow micronucleus protocol: results with 49 chemicals. Environ. Mol. Mutagen. 21 (1993) 160-179
23. Sugita T., Ishiwata H., and Maekawa A. Intestinal absorption and urinary excretion of melamine in male Wistar rats. Shokuhin Eiseigaku Zasshi 32 (1991) 439-443
24. Teeguarden J.G., Waechter Jr. J.M., Clewell III H.J., Covington T.R., and Barton H.A. Evaluation of oral and intravenous route pharmacokinetics, plasma protein binding, and uterine tissue dose metrics of bisphenol A: a physiologically based pharmacokinetic approach. Toxicol. Sci. 85 (2005) 823-838
25. Tranquilli W.J., Parks C.M., Thurmon J.C., Benson G.J., Koritz G.D., Manohar M., and Theodorakis M.C. Organ blood flow and distribution of cardiac output in nonanesthetized swine. Am. J. Vet. Res. 43 (1982) 895-897
26. Tsukamoto Y., Kato Y., Ura M., Horii I., Ishikawa T., Ishitsuka H., and Sugiyama Y. Investigation of 5-FU disposition after oral administration of capecitabine, a triple-prodrug of 5-FU, using a physiologically based pharmacokinetic model in a human cancer xenograft model: comparison of the simulated 5-FU exposures in the tumour tissue between human and xenograft model. Biopharm. Drug Dispos. 22 (2001) 1-14
27. US-EPA, 2006. Approaches for the Application of Physiologically Based Pharmacokinetic (PBPK) Models and Supporting Data in Risk Assessment (Final Report). US Environmental Protection Agency, Washington, DC.
28. US-FDA, 2007. Interim Melamine and Analogues Safety/Risk Assessment Peer Review Report. United States Food and Drug Administration, Washington, DC.
29. US-FDA, 2007. Interim Melamine and Analogues Safety/Risk Assessment. US Food and Drug Administration, Washington, DC.
30. USDA, 2007. Disposition of hogs and chickens from farms identified as having received pet food scraps contaminated with melamine and melamine-related compounds and offered for slaughter. United States Department of Agriculture, Washington, DC.
31. Young J.F., Wosilait W.D., and Luecke R.H. Analysis of methylmercury disposition in humans utilizing a PBPK model and animal pharmacokinetic data. J. Toxicol. Environ. Health A 63 (2001) 19-52